We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FXLV
4276
DELISTED
F45 Training Holdings Inc.
FXLV
$11K ﹤0.01%
+749
New +$11K
TLGA.U
4277
DELISTED
TLG Acquisition One Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TLGA.U
$11K ﹤0.01%
1,065
-459
-30% -$4.54K
DALS
4278
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$11K ﹤0.01%
+1,085
New +$10.7K
GRNA
4279
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$11K ﹤0.01%
1,110
+979
+747% +$9.6K
FNCH
4280
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$11K ﹤0.01%
28
+26
+1,300% +$11.1K
CNCE
4281
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$11K ﹤0.01%
3,325
-2,975
-47% -$10.4K
IVC
4282
DELISTED
Invacare Corporation
IVC
$11K ﹤0.01%
2,254
-3,311
-59% -$24.2K
DRAYU
4283
DELISTED
Macondray Capital Acquisition Corp. I Unit
DRAYU
$11K ﹤0.01%
+1,109
New +$11K
SPNE
4284
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$11K ﹤0.01%
721
-1,261
-64% -$21.6K
HCIC
4285
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$11K ﹤0.01%
+1,047
New +$10.4K
HTGM
4286
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$11K ﹤0.01%
+166
New +$11.9K
TMBR
4287
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$11K ﹤0.01%
251
+233
+1,294% +$11.4K
EDNCU
4288
DELISTED
Endurance Acquisition Corp. Unit
EDNCU
$11K ﹤0.01%
+1,111
New +$11K
CNVY
4289
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$11K ﹤0.01%
1,369
-3,377
-71% -$30.1K
HMTV
4290
DELISTED
Hemisphere Media Group, Inc.
HMTV
$11K ﹤0.01%
885
-452
-34% -$5.5K
MSP
4291
DELISTED
Datto Holding Corp.
MSP
$11K ﹤0.01%
450
-57
-11% -$1.48K
CHPM
4292
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
$11K ﹤0.01%
1,124
+406
+57% +$4.05K
TRIT
4293
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
$11K ﹤0.01%
1,811
+769
+74% +$4.18K
BOWX
4294
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
$11K ﹤0.01%
1,054
-1,771
-63% -$18.2K
ITAC
4295
DELISTED
Industrial Tech Acquisitions, Inc. Class A common stock
ITAC
$11K ﹤0.01%
+1,102
New +$11.1K
GNCA
4296
DELISTED
Genocea Biosciences, Inc.
GNCA
$11K ﹤0.01%
5,902
-2,672
-31% -$5.25K
NAVB
4297
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$11K ﹤0.01%
+6,394
New +$10.8K
PFSW
4298
DELISTED
PFSweb, Inc.
PFSW
$11K ﹤0.01%
837
-822
-50% -$10.3K
ABOS icon
4299
Acumen Pharmaceuticals
ABOS
$184M
$10K ﹤0.01%
+695
New +$11.6K
ACNT icon
4300
Ascent Industries
ACNT
$134M
$10K ﹤0.01%
936
-1,273
-58% -$13.6K
170 171
172
173 174

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.